IRIS
PACINI, FURIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.410
EU - Europa 7.529
AS - Asia 3.616
SA - Sud America 657
AF - Africa 183
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.318
GB - Regno Unito 2.204
CN - Cina 1.321
RU - Federazione Russa 1.311
SG - Singapore 1.107
IE - Irlanda 919
IT - Italia 773
UA - Ucraina 562
BR - Brasile 528
SE - Svezia 500
VN - Vietnam 395
FR - Francia 394
DE - Germania 373
HK - Hong Kong 286
FI - Finlandia 224
KR - Corea 157
IN - India 101
ZA - Sudafrica 101
NL - Olanda 75
AR - Argentina 48
TR - Turchia 47
CA - Canada 38
ES - Italia 35
BD - Bangladesh 33
MX - Messico 30
BE - Belgio 29
PL - Polonia 29
IQ - Iraq 28
JP - Giappone 26
MA - Marocco 20
VE - Venezuela 18
NG - Nigeria 17
AT - Austria 16
PK - Pakistan 15
EC - Ecuador 14
PY - Paraguay 14
CL - Cile 13
AU - Australia 12
CZ - Repubblica Ceca 11
TN - Tunisia 11
UZ - Uzbekistan 11
CO - Colombia 9
KE - Kenya 9
SA - Arabia Saudita 9
CH - Svizzera 8
EU - Europa 8
JO - Giordania 8
LT - Lituania 8
BG - Bulgaria 7
CI - Costa d'Avorio 7
ID - Indonesia 7
IR - Iran 7
JM - Giamaica 7
OM - Oman 7
AL - Albania 6
GR - Grecia 6
IL - Israele 6
NP - Nepal 6
PT - Portogallo 6
RO - Romania 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
EG - Egitto 5
HU - Ungheria 5
LB - Libano 5
NZ - Nuova Zelanda 5
PA - Panama 5
BO - Bolivia 4
EE - Estonia 4
PH - Filippine 4
BY - Bielorussia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KZ - Kazakistan 3
MD - Moldavia 3
PE - Perù 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CR - Costa Rica 2
CU - Cuba 2
DK - Danimarca 2
ET - Etiopia 2
LV - Lettonia 2
MY - Malesia 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
Totale 21.410
Salva come PNG Salva come JPEG
Città #
Southend 2.031
Fairfield 1.241
Dublin 901
Dallas 853
Ashburn 683
Woodbridge 584
Chandler 581
Singapore 559
Wilmington 468
Seattle 453
Jacksonville 452
Houston 438
Santa Clara 432
Cambridge 399
Beijing 339
Moscow 326
Ann Arbor 286
Siena 279
Hong Kong 272
The Dalles 179
Hefei 158
Seoul 154
Nanjing 153
Princeton 147
San Jose 147
Los Angeles 142
Helsinki 112
Ho Chi Minh City 103
Lauterbourg 96
Johannesburg 87
Hanoi 85
Boardman 81
Council Bluffs 73
Munich 66
New York 65
San Diego 64
Dong Ket 56
Nanchang 55
Buffalo 49
Amsterdam 47
São Paulo 45
Saint Petersburg 40
San Mateo 40
London 38
Milan 38
Florence 37
Shanghai 37
Düsseldorf 36
Tianjin 31
Turku 30
Shenyang 29
Brussels 27
Chicago 27
Kunming 27
Chennai 26
Jiaxing 26
Lancaster 26
Changsha 25
Guangzhou 25
Hebei 24
Columbus 23
Frankfurt am Main 23
Orem 23
Washington 22
Izmir 21
Jinan 21
Prato 20
Dearborn 19
Tokyo 19
Norwalk 18
Redwood City 18
Zhengzhou 18
Abuja 17
Haiphong 17
Redondo Beach 17
Warsaw 17
Brooklyn 15
Denver 15
Málaga 15
Ningbo 15
Phoenix 15
Belo Horizonte 14
Montreal 14
Rome 14
San Francisco 14
Da Nang 13
Renton 13
Ankara 12
Biên Hòa 12
Brasília 12
Manchester 12
Rio de Janeiro 12
Venezia 12
Bengaluru 11
Baghdad 10
East Falmouth 10
Hangzhou 10
Stockholm 10
Vienna 10
Atlanta 9
Totale 14.942
Salva come PNG Salva come JPEG
Nome #
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer 451
null 398
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer 369
Alterations of the FSH and LH receptor genes and evaluation of sperm ultrastructure in men with idiopathic hypergonadotropic hypogonadism 339
Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor 311
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 307
Obesity Does Not Modify the Risk of Differentiated Thyroid Cancer in a Cytological Series of Thyroid Nodules 304
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 299
Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias 293
Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes 290
Weight loss associated with bariatric surgery does not restore short telomere length of severe obese patients after 1 year 289
Approach to and treatment of differentiated thyroid carcinoma 284
A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer 281
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 275
Acute exogenous TSH administration stimulates leptin secretion in vivo 270
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma 265
Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients 263
Reference range of serum calcitonin in pediatric population 262
Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients 260
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB) 247
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question 243
Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients 242
A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment 237
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series 237
Definition and management of radioactive iodine-refractory differentiated thyroid cancer 236
Presurgical serum thyroglobulin has no prognostic value in papillary thyroid cancer 236
Lack of Mutations of the Telomerase RNA Component in Familial Papillary Thyroid Cancer with Short Telomeres 235
Management of thyroid nodules: a clinicopathological, evidence-based approach 234
Mutations and polymorphism of LH and FSH receptors and sperm quality in men with hypergonadotropic hypogonadism without obvious testicular noxa 231
Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients 227
Changing natural history of differentiated thyroid cancer 226
Clinical relevance of thyroglobulin doubling time in the management of patients with differentiated thyroid cancer 222
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update 222
Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab 220
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 218
Management of papillary thyroid microcarcinoma: primum non nocere! 216
Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer 214
Calcitonin Levels in Thyroid Disease Are Not Affected by Autoimmune Thyroiditis or Differentiated Thyroid Carcinoma 214
Variants in MCT10 protein do not affect FT3 levels in athyreotic patients 213
Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. 212
Telomere Abnormalities and Chromosome Fragility in Patients Affected by Familial Papillary Thyroid Cancer 212
Medullary thyroid carcinoma 211
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone 208
Serum Ghrelin As a Marker of Atrophic Body Gastritis in Patients With Parietal Cell Antibodies 201
Ernest L. Mazzaferri, MD, MACP (1936-2013) 201
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 199
Validation of American Thyroid Association Ultrasound Risk-Adapted Approach for Repeating Cytology in Benign Thyroid Nodules 199
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 197
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up 195
Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients 194
Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients 194
H. pylori (hp) infection and autoimmune diseases (ad): prevalence of infection in patients with Hashimoto's thyroiditis (ht) and allignement of thyroid hormones (th) with H. pylori proteins. 189
Best practice & research clinical endocrinology & metabolism. Thyroid nodules and cancer. Preface 188
Molecular signature of indeterminate thyroid lesions: Current methods to improve fine needle aspiration cytology (FNAC) diagnosis 188
Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? 186
Post-thyroidectomy chronic asthenia: self-deception or disease? 184
Screening of thyroid nodules by serum calcitonin measurements: why not? 183
Long-term efficacy of modified-release recombinant human thyrotropin augmented radioiodine therapy for benign multinodular goiter: results from a multicenter, international, randomized, placebo-controlled, dose-selection study 183
IFNγ-Inducible Chemokines Decrease upon Selenomethionine Supplementation in Women with Euthyroid Autoimmune Thyroiditis: Comparison between Two Doses of Selenomethionine (80 or 160 μg) versus Placebo 182
Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer 181
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients 180
Management of differentiated thyroid cancer of the follicular epithelium 179
Observation for newly diagnosed micro-papillary thyroid cancer: is now the time? 179
Prevalence of parietal cell antibodies in a large cohort of patients with autoimmune thyroiditis 179
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cute-off level for RET/PTC rearrangements. 177
Genetic heterogeneity of HER2 amplification and telomere shortening in papillary thyroid carcinoma 176
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology 176
Effects of Acute Recombinant Human TSH on Serum Ghrelin Levels 175
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. 173
Knockdown of IG20 gene expression renders thyroid cancer cells susceptible to apoptosis 172
Radioactive iodine-refractory differentiated thyroid cancer: unmet needs and future directions 172
Multinodular goiter of unusual shape and location 171
HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series 171
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal 170
How Far Should We Go in the Search and Treatment of Recurrent or Persistent Lymph Node Metastases during Follow-Up of Thyroid Cancer Patients? 168
Telomeres and thyroid cancer 166
Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. 165
Response Letter to the Editor from Edmundo Avila-Hipolito: "Long-term effects of radioiodine in toxic multinodular goitre: thyroid volume, function and autoimmunity" 165
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 164
The low utility of pretherapy scans in thyroid cancer patients 162
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 162
Extracellular superoxide dismutase induces mouse embryonic fibroblast proliferative burst, growth arrest, immortalization, and consequent in vivo tumorigenesis 161
A case of papillary thyroid cancer without aggressive histological features with nodal metastases detected during follow-up in a younger patients 161
Radioiodine therapy in the different stages of differentiated thyroid cancer 160
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer 160
Management of advanced medullary thyroid cancer 158
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study 157
New insight in the follow-up strategies of differentiated thyroid cancer 157
Targeted therapy in refractory thyroid cancer: current achievements and limitations 156
Rare diseases in clinical endocrinology: a taxonomic classification system 154
Bariatric Surgery Reduces Serum Anti-mullerian Hormone Levels in Obese Women With and Without Polycystic Ovarian Syndrome 152
Medullary thyroid cancer: management guidelines of the American Thyroid Association 150
Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand 149
Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study 149
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium 146
Thyroid microcarcinoma 145
Manuale di medicina interna 137
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer 136
The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma 135
null 126
Totale 20.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021571 0 0 0 0 0 0 0 0 0 230 161 180
2021/20221.267 132 183 69 94 68 51 62 41 81 141 141 204
2022/20231.929 113 171 256 267 193 378 38 169 211 32 72 29
2023/20241.243 67 30 106 39 52 348 455 19 6 18 16 87
2024/20252.822 54 137 241 138 385 196 96 140 237 96 393 709
2025/20265.508 525 908 623 725 1.047 290 694 212 237 247 0 0
Totale 21.611